Skip to content

senate · Committee report

S. Rept. 119-111

RESTORING CONFIDENCE IN THE WORLD ANTI-DOPING AGENCY ACT OF 2025

2026-02-23

Committees

Associated legislation

Text

Section-by-Section Analysis

Section 1. Short title. This section would provide that the Act may be cited as the ``Restoring Confidence in the World Anti-Doping Agency Act of 2025''. Section 2. Authority of National Drug Control Policy with respect to the World Anti-Doping Agency. This section would amend the Office of National Drug Control Policy Reauthorization Act of 2006 to add new definitions for the terms ``amateur athlete'', ``amateur athletic competition'', ``independent athlete'', and ``United States Olympic and Paralympic Committee''. This section would also require ONDCP, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council, to make an annual determination as to whether WADA meets the following criteria: Has a credible and independent governance model that provides for fair representation of the United States; Fully implements or has implemented governance reforms to ensure independent governance; and Has fair processes and procedures to select independent athletes, including athletes from the United States and other democratic countries (or their representatives), for decisionmaking roles within WADA. In the event WADA cannot meet these criteria, this section would (1) require ONDCP to use all available tools to bring WADA into compliance with such criteria; and (2) file a report to Congress that describes the barriers to participation and fair representation of the United States on WADA's Executive Committee and other decision-making bodies within WADA. This section would also permit ONDCP, in the event WADA cannot meet the above criteria, to voluntarily withhold up to the full amount of any funds made available for the payment of the United States membership dues to WADA. This section would further provide that any funds withheld would be required to be returned to the general fund at the end of the applicable fiscal year, unless otherwise specified by law. This section would require that if ONDCP were to obligate funds to WADA, it would need to submit a spending plan to the appropriate committees of Congress along with an explanation of how WADA meets the above criteria. Finally, this section would define the appropriate committees of Congress as the Committee on Commerce, Science, and Transportation of the Senate; the Committee on Appropriations of the Senate; the Committee on Energy and Commerce of the House of Representatives; and the Committee on Appropriations of the House of Representatives. Changes in Existing Law In compliance with paragraph 12 of rule XXVI of the Standing Rules of the Senate, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new material is printed in italic, existing law in which no change is proposed is shown in roman): OFFICE OF NATIONAL DRUG CONTROL POLICY REAUTHORIZATION ACT OF 2006 * * * * * * * TITLE VII--ANTI-DOPING AGENCY [21 U.S.C. 2001; Public Law 117-103] SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY. [(a) Definitions.--In this title: [(1) United states olympic committee.--The term ``United States Olympic Committee'' means the organization established by the ``Ted Stevens Olympic and Amateur Sports Act'' (36 U.S.C. 220501 et seq.). [(2) Amateur athletic competition.--The term ``amateur athletic competition'' means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)). [(3) Amateur athlete.--The term ``amateur athlete'' means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. 22501(b)(1)).] (a) Definitions.--In this subchapter: (1) Amateur athlete.--The term ``amateur athlete'' has the meaning given that term in section 220501(b)(1) of title 36, United States Code. (2) Amateur athletic competition.--The term ``amateur athletic competition'' has the meaning given that term in section 220501(b)(2) of title 36, United States Code. (3) Independent athlete.--The term ``independent athlete'' means a current or former amateur athlete who does not serve, in any capacity-- (A) on the International Olympic Committee; (B) on the International Paralympic Committee; (C) at an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee; (D) on the United States Olympic and Paralympic Committee; (E) at a national governing body (as defined in section 220501(b)(9) of title 36, United States Code); or (F) at the World Anti-Doping Agency. (4) United states olympic and paralympic committee.-- The term ``United States Olympic and Paralympic Committee'' means the organization established by chapter 2205 of title 36, United States Code. (b) In General.--The United States Anti-Doping Agency shall-- (1)(A) serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic and Paralympic Committee; (B) be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and (C) be recognized worldwide as the independent national anti-doping organization for the United States; (2) ensure that athletes participating in amateur athletic activities recognized by the [United States Olympic Committee] United States Olympic and Paralympic Committee are prevented from using performance- enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; (3) implement anti-doping education, research, testing, and adjudication programs to prevent United States Amateur Athletes participating in any activity recognized by the [United States Olympic Committee] United States Olympic and Paralympic Committee from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; (4) serve as the United States representative responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the [United States Olympic Committee] United States Olympic and Paralympic Committee to ensure the integrity of athletic competition, the health of the athletes, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance- enhancing methods adopted by the Agency; and (5) promote a positive youth sport experience by using a portion of the funding of the United States Anti-Doping Agency to provide educational materials on sportsmanship, character building, and healthy performance for the athletes, parents, and coaches who participate in youth sports. (c) Due Process in Arbitration Proceedings.--Any action taken by the United States Anti-Doping Agency to enforce a policy, procedure, or requirement of the United States Anti-Doping Agency against a person with respect to a violation of Federal law, including an investigation, a disciplinary action, a sanction, or any other administrative action, shall be carried out in a manner that provides due process protection to the person. (d) Authority With Respect to the World Anti-Doping Agency.-- (1) Annual determination.--Not later than 180 days after the date of the enactment of this subsection, and annually thereafter, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code) shall make a determination as to whether the World Anti- Doping Agency-- (A) has a credible and independent governance model that provides for fair representation of the United States; (B) fully implements or has implemented governance reforms to ensure independent governance; and (C) has fair processes and procedures to select independent athletes, including athletes from the United States and other democratic countries, or representatives of such athletes, for decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency. (2) Accountability.--In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code), shall use all available tools and best efforts to bring the World Anti-Doping Agency into compliance with the criteria set forth in that paragraph. (3) Report.--In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, not later than 180 days after the date on which that determination is made, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code) shall submit to the appropriate committees of Congress a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency. (4) Voluntary nonpayment of dues.-- (A) In general.--In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of any funds made available for the payment of the United States membership dues to the World Anti-Doping Agency. (B) Return of funds after noncompliance.-- Unless otherwise specified by law, any funds made available for the payment of the United States membership dues to the World Anti-Doping Agency that have been voluntarily withheld pursuant to subparagraph (A) and have not been obligated prior to the end of an applicable fiscal year shall be returned to the general fund of the Treasury. (5) Spending plan.--Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the appropriate committees of Congress a spending plan and explanation of proposed uses of such funds. (6) Appropriate committees of congress defined.--In this subsection, the term `appropriate committees of Congress' means-- (A) the Committee on Commerce, Science, and Transportation of the Senate; (B) the Committee on Appropriations of the Senate; (C) the Committee on Energy and Commerce of the House of Representatives; and (D) the Committee on Appropriations of the House of Representatives. * * * * * * * [all]

Source: https://api.congress.gov/v3/committee-report/119/srpt/111